49 Lumacaftor/ivacaftor (LUM/IVA) treatment in patients (pts) with cystic fibrosis (CF) aged ≥12 years homozygous for F508del-CFTR: description of a French Temporary Authorization for Use (ATU) cohort

Authors :: D. Hubert
Raphaël Chiron
Philippe Reix
P. Kiefer
S. Tian
V. Collas-Aubert
N. Kinnman
Source :: Journal of Cystic Fibrosis. 16:S76
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Pulmonary and Respiratory Medicine
Pediatrics
medicine.medical_specialty
business.industry
Lumacaftor
Authorization
medicine.disease
Cystic fibrosis
Ivacaftor
chemistry.chemical_compound
chemistry
Pediatrics, Perinatology and Child Health
Cohort
medicine
F508del cftr
In patient
business
medicine.drug

Tools